Yıl: 2019 Cilt: 34 Sayı: 3 Sayfa Aralığı: 317 - 325 Metin Dili: İngilizce DOI: 10.5606/ArchRheumatol.2019.7145 İndeks Tarihi: 29-01-2020

Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis

Öz:
Objectives: This study aims to evaluate the cardiopulmonary functions and exercise performance of patients with ankylosing spondylitis (AS) andto investigate the relationship between these parameters and disease activity, spine mobility and quality of life (QoL).Patients and methods: Forty-five patients with AS (group 1; 33 males, 12 females; mean age 43.1±12.1 years; range 22 to 70 years) and 30 controlsubjects (group 2; 23 males, 7 females; mean age 42.8±10.0; range 23 to 70 years) were included in the study. Disease activity was assessed with theBath Ankylosing Spondylitis Disease Activity Index and spinal mobility measures with the Bath Ankylosing Spondylitis Metrology Index (BASMI). TheAnkylosing Spondylitis Quality of Life (ASQoL) Questionnaire and the Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) were used. Thepulmonary function test (PFT) and cardiopulmonary exercise testing (CPET) were performed.Results: There was no significant difference between groups 1 and 2 in terms of mean age. The peak expiratory flow value in PFT was significantlylower in group 1 (p<0.05). In group 1, the duration of CPET was significantly shorter, and maximum work load and metabolic equivalent weresignificantly lower than in group 2 (p<0.001). Maximum oxygen uptake (VO2max) in peak responses, work and heart rate were significantly lower ingroup 1. The duration of CPET and maximum work were negatively correlated with age and BASMI (p<0.001). VO2max was negatively correlated withage, MASES and ASQoL (p<0.05).Conclusion: There was no significant difference in PFT parameters between the groups. On the other hand, CPET parameters were significantlylower in the AS group. While CPET parameters are affected by spinal mobility, declining aerobic capacity affects QoL.
Anahtar Kelime:

Konular: Romatoloji
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Braun J, Sieper J. Ankylosing spondylitis. Lancet 2007;369:1379-90.
  • 2. El Maghraoui A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med 2011;22:554-60.
  • 3. Gran JT, Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum 1993;22:319-34.
  • 4. Carbon RJ, Macey MG, McCarthy DA, Pereira FP, Perry JD, Wade AJ. The effect of 30 min cycle ergometry on ankylosing spondylitis. Br J Rheumatol 1996;35:167-77.
  • 5. Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation 1973;48:1014-27.
  • 6. Gould BA, Turner J, Keeling DH, Hickling P, Marshall AJ. Myocardial dysfunction in ankylosing spondylitis. Ann Rheum Dis 1992;51:227-32.
  • 7. Carter R, Riantawan P, Banham SW, Sturrock RD. An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis. Respir Med 1999;93:700-8.
  • 8. Hsieh LF, Wei JC3, Lee HY, Chuang CC, Jiang JS, Chang KC. Aerobic capacity and its correlates in patients with ankylosing spondylitis. Int J Rheum Dis 2016;19:490-9.
  • 9. O’Dwyer T, O’Shea F, Wilson F. Decreased physical activity and cardiorespiratory fitness in adults with ankylosing spondylitis: a cross-sectional controlled study. Rheumatol Int 2015;35:1863-72.
  • 10. Fisher LR, Cawley MI, Holgate ST. Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis. Ann Rheum Dis 1990;49:921-5.
  • 11. Feltelius N, Hedenström H, Hillerdal G, Hällgren R. Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis 1986;45:736-40.
  • 12. Franssen MJ, van Herwaarden CL, van de Putte LB, Gribnau FW. Lung function in patients with ankylosing spondylitis. A study of the influence of disease activity and treatment with nonsteroidal antiinflammatory drugs. J Rheumatol 1986;13:936-40.
  • 13. Heeneman S, Daemen MJ. Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol 2007;19:358-62.
  • 14. Seçkin U, Bölükbasi N, Gürsel G, Eröz S, Sepici V, Ekim N. Relationship between pulmonary function and exercise tolerance in patients with ankylosing spondylitis. Clin Exp Rheumatol 2000;18:503-6.
  • 15. Ceylan E. Cardiopulmonary exercise testing. J Clin Exp Invest 2014;5:504-9.
  • 16. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken) 2011;63:240-52.
  • 17. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
  • 18. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
  • 19. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J Rheumatol 1994;21:1694-8.
  • 20. Hidding A, van der Linden S, de Witte L. Therapeutic effects of individual physical therapy in ankylosing spondylitis related to duration of disease. Clin Rheumatol 1993;12:334-40.
  • 21. Wasserman K, Hansen JE, Sue DY, Stringer WW, Sietsema KE, Sun XG, et al. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2005
  • 22. Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, et al. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003;62:20-6.
  • 23. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewé R, van ver Tempel H, Mielants H, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003;62:127-32.
  • 24. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
  • 25. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:211-77.
  • 26. Elliott CG, Hill TR, Adams TE, Crapo RO, Nietrzeba RM, Gardner RM. Exercise performance of subjects with ankylosing spondylitis and limited chest expansion. Bull Eur Physiopathol Respir 1985;21:363-8.
  • 27. van der Esch M, van 't Hul AJ, Heijmans M, Dekker J. Respiratory muscle performance as a possible determinant of exercise capacity in patients with ankylosing spondylitis. Aust J Physiother 2004;50:41-5.
  • 28. Sampaio-Barros PD, Cerqueira EM, Rezende SM, Maeda L, Conde RA, Zanardi VA, et al. Pulmonary involvement in ankylosing spondylitis. Clin Rheumatol 2007;26:225-30.
  • 29. Halvorsen S, Vøllestad NK, Fongen C, Provan SA, Semb AG, Hagen KB, et al. Physical fitness in patients with ankylosing spondylitis: comparison with population controls. Phys Ther 2012;92:298-309.
  • 30. Roldan CA. Valvular and coronary heart disease in systemic inflammatory diseases: Systemic Disorders in heart disease. Heart 2008;94:1089-101.
  • 31. American College of Sports Medicine. In: Thompson WR, Gordon NF, Pescatello LS, editors. ACSM’s Guidelines for Exercise Testing and Prescription. Philadelphia: Lippincott Williams & Wilkins; 2010
  • 32. Pieringer H. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 2006;45:1319.
  • 33. Grassino A, Gross D, Macklem PT, Roussos C, Zagelbaum G. Inspiratory muscle fatigue as a factor limiting exercise. Bull Eur Physiopathol Respir 1979;15:105-15.
  • 34. Ozdem Yr O, Inanici F, Hasçelik Z. Reduced vital capacity leads to exercise intolerance in patients with ankylosing spondylitis. Eur J Phys Rehabil Med 2011;47:391-7.
  • 35. Berdal G, Halvorsen S, van der Heijde D, Mowe M, Dagfinrud H. Restrictive pulmonary function is more prevalent in patients with ankylosing spondylitis than in matched population controls and is associated with impaired spinal mobility: a comparative study. Arthritis Res Ther 2012;14:19.
APA ÇAĞLIYAN TÜRK A, Arslan S, KARAVELİOĞLU Y, Kalçık M, OZEL S, Musmul A, SAHIN F (2019). Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. , 317 - 325. 10.5606/ArchRheumatol.2019.7145
Chicago ÇAĞLIYAN TÜRK Ayla,Arslan Sertaç,KARAVELİOĞLU Yusuf,Kalçık Macit,OZEL SUMRU,Musmul Ahmet,SAHIN FÜSUN Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. (2019): 317 - 325. 10.5606/ArchRheumatol.2019.7145
MLA ÇAĞLIYAN TÜRK Ayla,Arslan Sertaç,KARAVELİOĞLU Yusuf,Kalçık Macit,OZEL SUMRU,Musmul Ahmet,SAHIN FÜSUN Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. , 2019, ss.317 - 325. 10.5606/ArchRheumatol.2019.7145
AMA ÇAĞLIYAN TÜRK A,Arslan S,KARAVELİOĞLU Y,Kalçık M,OZEL S,Musmul A,SAHIN F Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. . 2019; 317 - 325. 10.5606/ArchRheumatol.2019.7145
Vancouver ÇAĞLIYAN TÜRK A,Arslan S,KARAVELİOĞLU Y,Kalçık M,OZEL S,Musmul A,SAHIN F Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. . 2019; 317 - 325. 10.5606/ArchRheumatol.2019.7145
IEEE ÇAĞLIYAN TÜRK A,Arslan S,KARAVELİOĞLU Y,Kalçık M,OZEL S,Musmul A,SAHIN F "Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis." , ss.317 - 325, 2019. 10.5606/ArchRheumatol.2019.7145
ISNAD ÇAĞLIYAN TÜRK, Ayla vd. "Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis". (2019), 317-325. https://doi.org/10.5606/ArchRheumatol.2019.7145
APA ÇAĞLIYAN TÜRK A, Arslan S, KARAVELİOĞLU Y, Kalçık M, OZEL S, Musmul A, SAHIN F (2019). Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. Archives of Rheumatology, 34(3), 317 - 325. 10.5606/ArchRheumatol.2019.7145
Chicago ÇAĞLIYAN TÜRK Ayla,Arslan Sertaç,KARAVELİOĞLU Yusuf,Kalçık Macit,OZEL SUMRU,Musmul Ahmet,SAHIN FÜSUN Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. Archives of Rheumatology 34, no.3 (2019): 317 - 325. 10.5606/ArchRheumatol.2019.7145
MLA ÇAĞLIYAN TÜRK Ayla,Arslan Sertaç,KARAVELİOĞLU Yusuf,Kalçık Macit,OZEL SUMRU,Musmul Ahmet,SAHIN FÜSUN Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. Archives of Rheumatology, vol.34, no.3, 2019, ss.317 - 325. 10.5606/ArchRheumatol.2019.7145
AMA ÇAĞLIYAN TÜRK A,Arslan S,KARAVELİOĞLU Y,Kalçık M,OZEL S,Musmul A,SAHIN F Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. Archives of Rheumatology. 2019; 34(3): 317 - 325. 10.5606/ArchRheumatol.2019.7145
Vancouver ÇAĞLIYAN TÜRK A,Arslan S,KARAVELİOĞLU Y,Kalçık M,OZEL S,Musmul A,SAHIN F Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis. Archives of Rheumatology. 2019; 34(3): 317 - 325. 10.5606/ArchRheumatol.2019.7145
IEEE ÇAĞLIYAN TÜRK A,Arslan S,KARAVELİOĞLU Y,Kalçık M,OZEL S,Musmul A,SAHIN F "Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis." Archives of Rheumatology, 34, ss.317 - 325, 2019. 10.5606/ArchRheumatol.2019.7145
ISNAD ÇAĞLIYAN TÜRK, Ayla vd. "Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis". Archives of Rheumatology 34/3 (2019), 317-325. https://doi.org/10.5606/ArchRheumatol.2019.7145